Reason for request
Inscription
Mise à disposition d'un hybride de Xalatan.
Clinical Benefit
| Substantial |
Le service médical rendu par VIZILATAN 50 microgrammes/mL, collyre en solution est important dans les indications de l’AMM. |
Clinical Added Value
| no clinical added value |
La spécialité VIZILATAN 50 microgrammes/mL, collyre en solution n’apporte pas d’amélioration du service médical rendu (ASMR V) par rapport à la spécialité de référence XALATAN 50 microgrammes/mL, collyre en solution. |
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
U2y8nC5AruQyC54q
